The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

After recovering from Oropouche infection, symptoms recur in about 60% of patients within a few days up to several weeks.

New research this month shows that the experimental antiviral obeldesivir prevented up to 100% of deaths in monkeys infected ...

As well as protecting the monkeys from death, the treatment also evoked an immune response. Senior author Dr Thomas Geisbert ...

Tanzania declares the end of the Marburg virus outbreak, but Africa continues to battle rising health crises, including ...

In her new book 'A History of the World in Six Plagues,' Edna Bonhomme describes a 2014 epidemic that decimated a neighborhood — possibly foreshadowing what's to come.

The outbreak has been caused by a strain of the Ebola virus for which there are no approved ... including one of Marburg disease, another viral hemorrhagic fever — and its significant movement ...

Scientists suspect the first person infected with Ebola in an outbreak acquired the virus through contact ... latest in a trend of outbreaks of viral hemorrhagic fevers in the east African region.

Scientists suspect the first person infected with Ebola in an outbreak acquired the virus through contact ... latest in a trend of outbreaks of viral hemorrhagic fevers in the east African region.